N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide

C70H83N15O7 — CID 158122973

IUPACN-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide
SMILESCc1ccc(Cc2cc(C(=O)N[C@H]3CCCC[C@@H]3O)nc(-c3ccn(C)n3)c2C)cn1.Cc1ccc(Cc2cc(C(=O)N[C@H]3CCC[C@@H]3O)nc(-c3ccn(C)n3)c2C)cn1.Cc1ccc(Cc2cc(C(=O)N[C@H]3CCOC[C@@H]3O)nc(-c3ccn(C)n3)c2C)cn1
InChIInChI=1S/C24H29N5O2.C23H27N5O3.C23H27N5O2/c1-15-8-9-17(14-25-15)12-18-13-21(24(31)27-19-6-4-5-7-22(19)30)26-23(16(18)2)20-10-11-29(3)28-20;1-14-4-5-16(12-24-14)10-17-11-20(23(30)26-18-7-9-31-13-21(18)29)25-22(15(17)2)19-6-8-28(3)27-19;1-14-7-8-16(13-24-14)11-17-12-20(23(30)26-18-5-4-6-21(18)29)25-22(15(17)2)19-9-10-28(3)27-19/h8-11,13-14,19,22,30H,4-7,12H2,1-3H3,(H,27,31);4-6,8,11-12,18,21,29H,7,9-10,13H2,1-3H3,(H,26,30);7-10,12-13,18,21,29H,4-6,11H2,1-3H3,(H,26,30)/t19-,22-;2*18-,21-/m000/s1
InChIKeyFRVAZHNAOURGGC-GKFDOYFXSA-N
MW1246.53 g/mol
LogP7.81
Rot. Bonds15

About N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide

N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide (PubChem CID 158122973) has the molecular formula C70H83N15O7 and a molecular weight of 1246.53 g/mol. Its IUPAC name is N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide
PubChem CID158122973
Molecular FormulaC70H83N15O7
Molecular Weight1246.53 g/mol
Exact Mass1245.66
IUPAC NameN-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide
SMILESCc1ccc(Cc2cc(C(=O)N[C@H]3CCCC[C@@H]3O)nc(-c3ccn(C)n3)c2C)cn1.Cc1ccc(Cc2cc(C(=O)N[C@H]3CCC[C@@H]3O)nc(-c3ccn(C)n3)c2C)cn1.Cc1ccc(Cc2cc(C(=O)N[C@H]3CCOC[C@@H]3O)nc(-c3ccn(C)n3)c2C)cn1
InChIInChI=1S/C24H29N5O2.C23H27N5O3.C23H27N5O2/c1-15-8-9-17(14-25-15)12-18-13-21(24(31)27-19-6-4-5-7-22(19)30)26-23(16(18)2)20-10-11-29(3)28-20;1-14-4-5-16(12-24-14)10-17-11-20(23(30)26-18-7-9-31-13-21(18)29)25-22(15(17)2)19-6-8-28(3)27-19;1-14-7-8-16(13-24-14)11-17-12-20(23(30)26-18-5-4-6-21(18)29)25-22(15(17)2)19-9-10-28(3)27-19/h8-11,13-14,19,22,30H,4-7,12H2,1-3H3,(H,27,31);4-6,8,11-12,18,21,29H,7,9-10,13H2,1-3H3,(H,26,30);7-10,12-13,18,21,29H,4-6,11H2,1-3H3,(H,26,30)/t19-,22-;2*18-,21-/m000/s1
InChIKeyFRVAZHNAOURGGC-GKFDOYFXSA-N
XLogP7.81
TPSA288.02 Ų
H-Bond Donors6
H-Bond Acceptors19
Rotatable Bonds15
Heavy Atoms92
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001246.53
LogP ≤ 57.81
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1019

Analyze N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide?
The IUPAC name of N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide (CID 158122973) is N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide.
What is the SMILES notation for N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide?
The canonical SMILES for N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide is Cc1ccc(Cc2cc(C(=O)N[C@H]3CCCC[C@@H]3O)nc(-c3ccn(C)n3)c2C)cn1.Cc1ccc(Cc2cc(C(=O)N[C@H]3CCC[C@@H]3O)nc(-c3ccn(C)n3)c2C)cn1.Cc1ccc(Cc2cc(C(=O)N[C@H]3CCOC[C@@H]3O)nc(-c3ccn(C)n3)c2C)cn1.
What is the InChIKey of N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide?
The InChIKey is FRVAZHNAOURGGC-GKFDOYFXSA-N. The full InChI is InChI=1S/C24H29N5O2.C23H27N5O3.C23H27N5O2/c1-15-8-9-17(14-25-15)12-18-13-21(24(31)27-19-6-4-5-7-22(19)30)26-23(16(18)2)20-10-11-29(3)28-20;1-14-4-5-16(12-24-14)10-17-11-20(23(30)26-18-7-9-31-13-21(18)29)25-22(15(17)2)19-6-8-28(3)27-19;1-14-7-8-16(13-24-14)11-17-12-20(23(30)26-18-5-4-6-21(18)29)25-22(15(17)2)19-9-10-28(3)27-19/h8-11,13-14,19,22,30H,4-7,12H2,1-3H3,(H,27,31);4-6,8,11-12,18,21,29H,7,9-10,13H2,1-3H3,(H,26,30);7-10,12-13,18,21,29H,4-6,11H2,1-3H3,(H,26,30)/t19-,22-;2*18-,21-/m000/s1.
What are the key properties of N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide?
N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide has a molecular weight of 1246.53 g/mol, XLogP of 7.81, 15 rotatable bonds, 6 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S,2S)-2-hydroxycyclohexyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[(6-methyl-3-pyridinyl)methyl]pyridine-2-carboxamide is sourced from PubChem (CID 158122973), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).